Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Inv. presentation Director departure
|
Paratek Pharmaceuticals, Inc. (PRTK)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/14/2021 |
3
| Baylor-Henry Minnie (Director) has filed a Form 3 on Paratek Pharmaceuticals, Inc. |
09/27/2019 |
3
| Brenner Randall B. (Chief Development & Regulatory) has filed a Form 3 on Paratek Pharmaceuticals, Inc. |
04/23/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/11/2016 |
3
| Peterson Kristine (Director) has filed a Form 3 on Paratek Pharmaceuticals, Inc. |
09/05/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
04/11/2013 |
3
| Dietz Thomas John (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
06/26/2012 |
3
| PATTERSON LEONE D (Vice President, CFO) has filed a Form 3 on Transcept Pharmaceuticals Inc |
06/04/2012 |
3
| Kollins John A (SVP, Chief Business Officer) has filed a Form 3 on Transcept Pharmaceuticals Inc |
09/22/2011 |
3
| InterWest Partners IX, LP (10% Owner) has filed a Form 3 on Transcept Pharmaceuticals Inc |
09/22/2011 |
3
| InterWest Management Partners IX, LLC (10% Owner) has filed a Form 3 on Transcept Pharmaceuticals Inc |
03/12/2009 |
3
| Kennedy Joseph T (VP and General Counsel) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/06/2009 |
3
| New Leaf Ventures I, L.P. (10% Owner) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| LAPORTE KATHLEEN (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| TURNER DANIEL K III (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| KILEY THOMAS (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| Ehrlich Christopher B (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| RAAB G KIRK (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| Moore Terrence O (VP, Marketing and Sales) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| WORTZMAN MARILYN E (VP, Finance) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| Singh Nikhilesh N (SVP & Chief Scientific Officer) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| Koppy Susan (VP, Corporate Development) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| Soloway Thomas P (SVP, Operations and CFO) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/03/2009 |
3
| OCLASSEN GLENN A (President and CEO) has filed a Form 3 on Transcept Pharmaceuticals Inc |
02/02/2009 |
3
| Nunn Jason Raleigh (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
|
|